430 related articles for article (PubMed ID: 25280748)
1. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.
Baron-Franco B; McLean G; Mair FS; Roger VL; Guthrie B; Mercer SW
Br J Gen Pract; 2017 May; 67(658):e314-e320. PubMed ID: 28396366
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of polypharmacy in a Scottish primary care population.
Payne RA; Avery AJ; Duerden M; Saunders CL; Simpson CR; Abel GA
Eur J Clin Pharmacol; 2014 May; 70(5):575-81. PubMed ID: 24487416
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.
Barnett K; Mercer SW; Norbury M; Watt G; Wyke S; Guthrie B
Lancet; 2012 Jul; 380(9836):37-43. PubMed ID: 22579043
[TBL] [Abstract][Full Text] [Related]
5. Depression and multimorbidity: a cross-sectional study of 1,751,841 patients in primary care.
Smith DJ; Court H; McLean G; Martin D; Langan Martin J; Guthrie B; Gunn J; Mercer SW
J Clin Psychiatry; 2014 Nov; 75(11):1202-8; quiz 1208. PubMed ID: 25470083
[TBL] [Abstract][Full Text] [Related]
6. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
7. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care.
Chetty U; McLean G; Morrison D; Agur K; Guthrie B; Mercer SW
Br J Gen Pract; 2017 May; 67(658):e321-e328. PubMed ID: 28450344
[TBL] [Abstract][Full Text] [Related]
8. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.
Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M
BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080
[TBL] [Abstract][Full Text] [Related]
10. The influence of socioeconomic deprivation on multimorbidity at different ages: a cross-sectional study.
McLean G; Gunn J; Wyke S; Guthrie B; Watt GC; Blane DN; Mercer SW
Br J Gen Pract; 2014 Jul; 64(624):e440-7. PubMed ID: 24982497
[TBL] [Abstract][Full Text] [Related]
11. Double trouble: the impact of multimorbidity and deprivation on preference-weighted health related quality of life a cross sectional analysis of the Scottish Health Survey.
Lawson KD; Mercer SW; Wyke S; Grieve E; Guthrie B; Watt GC; Fenwick EA
Int J Equity Health; 2013 Aug; 12():67. PubMed ID: 23962150
[TBL] [Abstract][Full Text] [Related]
12. Multimorbidity in Māori and Pacific patients: cross-sectional study in a Dunedin general practice.
Stokes T; Azam M; Noble FD
J Prim Health Care; 2018 Mar; 10(1):39-43. PubMed ID: 30068450
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162,464 community household residents in southern China.
Wang HH; Wang JJ; Wong SY; Wong MC; Li FJ; Wang PX; Zhou ZH; Zhu CY; Griffiths SM; Mercer SW
BMC Med; 2014 Oct; 12():188. PubMed ID: 25338506
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy Among Privately Insured Adults with Cerebral Palsy: A Retrospective Cohort Study.
Whitney DG; Schmidt M; Peterson MD; Haapala H
J Manag Care Spec Pharm; 2020 Sep; 26(9):1153-1161. PubMed ID: 32857655
[TBL] [Abstract][Full Text] [Related]
15. Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross-sectional study.
Violán C; Foguet-Boreu Q; Roso-Llorach A; Rodriguez-Blanco T; Pons-Vigués M; Pujol-Ribera E; Muñoz-Pérez MÁ; Valderas JM
BMC Public Health; 2014 May; 14():530. PubMed ID: 24885174
[TBL] [Abstract][Full Text] [Related]
16. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study.
Holvast F; van Hattem BA; Sinnige J; Schellevis F; Taxis K; Burger H; Verhaak PFM
Fam Pract; 2017 Sep; 34(5):539-545. PubMed ID: 28369380
[TBL] [Abstract][Full Text] [Related]
17. Challenges of managing people with multimorbidity in today's healthcare systems.
Moffat K; Mercer SW
BMC Fam Pract; 2015 Oct; 16():129. PubMed ID: 26462820
[TBL] [Abstract][Full Text] [Related]
18. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
[TBL] [Abstract][Full Text] [Related]
19. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial factors associated with medication burden among community-dwelling older people with multimorbidity.
Yang C; Zhu S; Hui Z; Mo Y
BMC Geriatr; 2023 Nov; 23(1):741. PubMed ID: 37964196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
